UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,484,708 | -18.0% | 914,896 | +44.2% | 0.01% | -25.0% |
| Q1 2023 | $12,780,038 | +200151.3% | 634,560 | +125.4% | 0.02% | +77.8% |
| Q4 2022 | $6,382 | -99.8% | 281,530 | +32.8% | 0.01% | +50.0% |
| Q3 2022 | $3,976,000 | +29.6% | 211,930 | +28.8% | 0.01% | +50.0% |
| Q2 2022 | $3,067,000 | +43.6% | 164,535 | +39.2% | 0.00% | +100.0% |
| Q1 2022 | $2,136,000 | +20.1% | 118,203 | +37.8% | 0.00% | 0.0% |
| Q4 2021 | $1,779,000 | – | 85,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |